TCL Archive Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent. February 24, 2006
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG November 3, 1978